HomeBUSINESS
BUSINESS

Sumitomo Dainippon Scores Record Earnings on Latuda Boost
(May.15.2017)

Sumitomo Dainippon Pharma chalked up record sales and operating profit in the year ended March 2017 thanks to buoyant growth of its atypical antipsychotic Latuda (lurasidone) in North America, despite its sluggish performance in Japan ...
(LOG IN FOR FULL STORY)